Profiling the subjective, psychomotor, and physiological effects of tramadol in recreational drug users.

Author: ZacnyJames P

Paper Details 
Original Abstract of the Article :
Tramadol is a mu opioid agonist that also inhibits the reuptake of norepinephrine and serotonin. Because non-medical use of prescription opioids, including tramadol, has increased in the U.S. over the last several years, we sought to profile its subjective, psychomotor, and physiological effects in ...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1016/j.drugalcdep.2005.05.007

データ提供:米国国立医学図書館(NLM)

Tramadol: A Hidden Oasis in the Desert of Opioid Abuse?

The desert of opioid abuse is a dangerous and unforgiving place, where individuals struggle with addiction and its devastating consequences. This study investigates the potential for abuse liability of tramadol, a medication commonly used for pain relief, in individuals who use recreational drugs. The researchers conducted a randomized, double-blind study, where participants received either tramadol, morphine, or a placebo, finding that tramadol had subjective effects similar to those of morphine, suggesting a potential for abuse liability, particularly in individuals with a history of opioid use.

Navigating the Shifting Sands of Opioid Abuse

This study serves as a reminder that the desert of opioid abuse is a complex and challenging landscape, where even medications intended for pain relief can pose risks for misuse and addiction. The findings underscore the importance of careful prescribing practices, patient monitoring, and harm reduction strategies to mitigate the potential for abuse and addiction.

A Call for Vigilance in the Desert of Opioid Abuse

This research highlights the need for continued vigilance in the desert of opioid abuse, particularly when it comes to medications that may have potential for abuse liability. The findings underscore the importance of responsible prescribing practices, patient education, and ongoing monitoring to prevent misuse and minimize the risks associated with these medications.

Dr.Camel's Conclusion

This study is a reminder that the desert of opioid abuse is a dangerous and unforgiving landscape, where vigilance and careful decision-making are crucial for safeguarding patient health and well-being. The findings underscore the importance of understanding the potential risks of medications and developing strategies to prevent misuse and addiction, ensuring that individuals seeking relief from pain find a safe and sustainable path toward healing.

Date :
  1. Date Completed 2006-02-24
  2. Date Revised 2019-12-10
Further Info :

Pubmed ID

16005162

DOI: Digital Object Identifier

10.1016/j.drugalcdep.2005.05.007

Related Literature

Article Analysis
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.